Auxly Cannabis Group Inc. · TSX:XLY
Auxly Cannabis — Investor Presentation (April 2019)
21 slides from Auxly Cannabis's investor presentation, April 2019
Slide 1: Auxly Cannabis Group Investor Presentation
Auxly Cannabis Group Investor Presentation April 2019 Auxly Cannabis Group Inc www.auxly.com 1
Slide 2: Legal Disclaimer
Legal Disclaimer Forward-looking Information including risks related to the cannabis market in the United States, Europe, Latin America and The information provided herein is not intended to provide financial, tax, legal or accounting advice. This corporate document contains “forward-looking stateme
Slide 3: Auxly Investment Highlights: Positioned for success in the growing cannabis industry
AUXLY INVESTMENT HIGHLIGHTS: Positioned for success in the growing cannabis industry. HIGHLY EXPERIENCED AND SKILLED TEAM TO SUCCESSFULLY EXECUTE STRATEGY • Enterprising visionaries; global experience in CPG and operating in highly regulated environments DIVERSIFIED SUPPLY CHAIN PROVIDES A SECURE AN
Slide 4: #ThisIsAUXLY
#ThisIsAUXLY CANADA URUGUAY 11 PROJECTS Auxly Cannabis Group Inc www.auxly.com 4
Slide 5: A Team Dedicated to Growth
A TEAM DEDICATED TO GROWTH: Ambition, passion and commitment are in our DNA. Chuck Rifici Hugo Alves Mike Lickver Jeff Tung, CFA Chairman, Chief Executive Officer Director, President Senior Vice President, Strategy Chief Operating Officer • Co-founder of Canopy Growth (formerly Tweed • Former senior
Slide 6: Global Market Opportunity: Auxly strategically positioned in multiple jurisdictions
GLOBAL MARKET OPPORTUNITY: Auxly strategically positioned in multiple jurisdictions. Global Cannabis Market Estimated at US $250bn* Canada • Cultivation assets and partnerships yielding over 100,000KG of cannabis at scale across 9 partners and wholly owned subsidiaries • 42,000 square foot wholly-ow
Slide 7: Cultivation Projects: Diversified source of supply
CULTIVATION PROJECTS: Diversified source of supply of over 100,000 kgs per annum. Attributable Initial First Product Description Location Facility Size Operational Stage Structure Annual Production Delivery Date Large-scale outdoor Montevideo, 187 Hectares 1,000kg+ of CBD Licensed and Q4 2019 80% Ow
Slide 8: Kolab Project
KOLAB PROJECT Purpose-build indoor The KOLAB PROJECT is a wholly owned subsidiary of Auxly and a sales licensed producer pursuant to Description: cannabis cultivation the Cannabis Act located near Ottawa, Ontario. KOLAB Project seeks to differentiate its cannabis Location: Carleton Place, Ontario of
Slide 9: Robinsons Cannabis
ROBINSONS CANNABIS Ultra-premium indoor Robinson’s Cannabis is a wholly owned subsidiary of Auxly Cannabis Group and a late-stage licensed Description: cannabis cultivation producer applicant pursuant to the Cannabis Act located in Kentville, Nova Scotia. The application Location: Kentville, Nova Sc
Slide 10: Sunens
SUNENS Sunens Sunens (formerly GreenhouseCo) is a joint venture with world renown cultivation expert Peter Quiring via a newly formed subsidiary. Description: Large-scale greenhouse cannabis cultivation The first phase of Sunens will be to develop an initial 1.4 million square feet of greenhouse in
Slide 11: Inverell S.A.: Building the dominant cultivation and extraction footprint in LATAM
INVERELL S.A.: Building the dominant cultivation and extraction footprint in LATAM. OVERVIEW OF OPERATIONS EXTRACTION AND MANUFACTURING SALES AND DISTRIBUTION • Extraction facility located within a 55 ha science focused • Actively negotiating • Large-scale licensed cannabis operator in Montevideo, U
Slide 12: Product Development: Dosecann equipping Auxly to capture derivative market share
PRODUCT DEVELOPMENT: Dosecann equipping Auxly to capture market share as soon derivative products are legalized. Gross Margin Comparison Across Product Lines Dosecann Product Focus Gross Margin (Gross Margin % above bar) Cost of Sales 50 40 Selling Price Per Gram Equivalent 30 Key Facts and Figures
Slide 13: Strategic Partners
STRATEGIC PARTNERS: With our deep industry connections, we have partnered with leaders in the cannabis industry to leverage best practices, accelerate growth and bring the best products to market. KGK Science Dixie Brands Province Brands Spiritleaf KGK Science is a wholly owned subsidiary of Dixie B
Slide 14: Domestic Distribution Channels
DOMESTIC DISTRIBUTION CHANNELS: Focus on higher margin medical channels, wholly-owned retail, provincial retailers and strategic partners. Medical Wholly-Owned Retail Outlets Kolab Project: Auxly has a wholly owned licensed facility in Kolab Project: Obtained permit to operate a cannabis retail Carl
Slide 15: Strategic Focus Over the Next 12 Months
STRATEGIC FOCUS OVER THE NEXT 12 MONTHS: Focused on high-margin, value-added branded medical and adult-use derivative products. KEY MILESTONES Anticipated normalized state of the adult-use Health Canada introduces Sale of edibles and market draft regulations for other derivative Legalization and fir
Slide 16: Capitalization Table
CAPITALIZATION TABLE: Strong cash position; well-positioned to execute on strategic objectives. SHARE STRUCTURE AS OF DECEMBER 31, 2018 AMOUNT PERCENTAGE Common Shares Outstanding 581.4M 73.4% Stock Options (weighted average exercise price of $0.889) 39.6M 5.0% Warrants (weighted average exercise pr
Slide 17: Appendix
Appendix
Slide 18: Appendix: Our Subsidiaries
APPENDIX: Our subsidiaries. Inverell Summary Kolab Project Robinsons Cannabis Dosecann KGK Science Location: Uruguay Location: Ontario, Canada Location: Nova Scotia, Canada Location: Prince Edward Island, Location: Ontario, Canada Canada Facility Type: Outdoor Facility Type: Indoor Facility Type: In
Slide 19: Culture of Leadership
CULTURE OF LEADERSHIP: Our people are the key to our success. 310 employees across Auxly head office and subsidiaries • 23 PhDs • 117 Science degrees • 36 Masters degrees • 5 Medical Doctorates Dr. Tina Woollard Dr. Bob Chapman Peter Crooks Najla Guthrie Dr. Raúl Urbina Chief Science Officer, Doseca
Slide 20: Board of Directors
BOARD OF DIRECTORS: Governance in support of Auxly’s strategy. Chuck Rifici Genevieve Young Jean-Paul Gaillard Troy Grant Chairman, Chief Executive Officer Independent Director Independent Director Independent Director Genevieve Young is the President and Jean-Paul Gaillard is a seasoned Since 2000,
Slide 21: For More Information Contact
FOR MORE INFORMATION CONTACT: ir@auxly.com 1 833 695 2414
Auxly Cannabis Group — Investor Presentation (April 2019) on 6ix